Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
151.2 USD | -0.07% | -0.16% | -3.57% |
11:46am | J&J: positive trial for Tremfya in ulcerative colitis | CF |
11:41am | Valneva Names New Chief Scientific Officer | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-3.57% | 364B | |
+37.85% | 705B | |
+32.82% | 583B | |
+20.44% | 332B | |
+5.43% | 291B | |
+16.64% | 238B | |
-4.13% | 210B | |
+10.63% | 209B | |
+8.49% | 169B | |
-1.49% | 162B |
- Stock Market
- Equities
- JNJ Stock
- News Johnson & Johnson
- Raymond James Adjusts Johnson & Johnson's Price Target to $185 From $178, Keeps Outperform Rating